Paul Edward Walker
CIK: 0001553150
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (37 total)
- Mar 10, 2026KRRO
Korro Bio, Inc.
Purchase(P)Indirect207.1K shares at avg. $11.11$2.3M - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Conversion(C)Indirect1.6M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Conversion(C)Indirect1.4M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Conversion(C)Indirect1.4M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Conversion(C)Indirect738K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Purchase(P)Indirect937.5K shares at avg. $16.00$15.0M - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Conversion(C)Indirect402.3K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
Conversion(C)Indirect955K shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
Award(A)IndirectWarrant (Right to Buy)
124.1K shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
In-the-Money(X)Indirect1.7M shares at avg. $0.01$17K - Oct 2, 2025NEUE
NeueHealth, Inc.
Sale(S)Indirect2.5K shares at avg. $6.75$17K - Oct 2, 2025NEUE
NeueHealth, Inc.
In-the-Money(X)Indirect607.5K shares at avg. $0.01$6K - Oct 2, 2025NEUE
NeueHealth, Inc.
Sale(S)Indirect900 shares at avg. $6.75$6K - Oct 2, 2025NEUE
NeueHealth, Inc.
Exercise(M)Indirect124.1K shares at avg. $0.01$1K - Oct 2, 2025NEUE
NeueHealth, Inc.
Tax Payment(F)Indirect182 shares at avg. $6.75$1K - Oct 2, 2025NEUE
NeueHealth, Inc.
Disposition(D)Indirect2.4M shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
Award(A)IndirectWarrant (Right to Buy)
372.3K shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
Award(A)IndirectWarrant (Right to Buy)
186.1K shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
In-the-Money(X)Indirect189.2K shares at avg. $0.01$2K - Oct 2, 2025NEUE
NeueHealth, Inc.
Sale(S)Indirect280 shares at avg. $6.75$2K - Oct 2, 2025NEUE
NeueHealth, Inc.
Exercise(M)Indirect372.3K shares at avg. $0.01$4K - Oct 2, 2025NEUE
NeueHealth, Inc.
Tax Payment(F)Indirect551 shares at avg. $6.75$4K - Oct 2, 2025NEUE
NeueHealth, Inc.
Disposition(D)Indirect1.2M shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
In-the-Money(X)Indirect189.2K shares at avg. $0.01$2K - Oct 2, 2025NEUE
NeueHealth, Inc.
Sale(S)Indirect280 shares at avg. $6.75$2K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 10, 2026 |  KRRO Korro Bio, Inc. | Purchase(P) | 207,100 | $11.11 | $2,300,881 | Indirect |
| Feb 9, 2026 |  SGP SpyGlass Pharma, Inc. | Conversion(C) | 1,619,240 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion(C) | 1,370,168 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion(C) | 1,370,168 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion(C) | 737,962 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Purchase(P) | 937,500 | $16.00 | $15,000,000 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion(C) | 402,273 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion(C) | 954,990 | - | $0 | Indirect |
| Oct 2, 2025 |  NEUE NeueHealth, Inc. | Award(A) Warrant (Right to Buy) | 124,085 | - | - | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | In-the-Money(X) | 1,656,789 | $0.01 | $16,568 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Sale(S) | 2,455 | $6.75 | $16,571 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | In-the-Money(X) | 607,536 | $0.01 | $6,075 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Sale(S) | 900 | $6.75 | $6,075 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Exercise(M) | 124,085 | $0.01 | $1,241 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Tax Payment(F) | 182 | $6.75 | $1,229 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Disposition(D) | 2,384,873 | - | - | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Award(A) Warrant (Right to Buy) | 372,255 | - | - | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Award(A) Warrant (Right to Buy) | 186,128 | - | - | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | In-the-Money(X) | 189,195 | $0.01 | $1,892 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Sale(S) | 280 | $6.75 | $1,890 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Exercise(M) | 372,255 | $0.01 | $3,723 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Tax Payment(F) | 551 | $6.75 | $3,719 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Disposition(D) | 1,159,683 | - | - | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | In-the-Money(X) | 189,195 | $0.01 | $1,892 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Sale(S) | 280 | $6.75 | $1,890 | Indirect |
1-25 of 37 transactions
About Walker Paul Edward
Walker Paul Edward (SEC CIK 0001553150) files insider reports with the SEC as 10% Owner of Korro Bio, Inc. (KRRO), 10% Owner of Trevi Therapeutics, Inc. (TRVI) and 10% Owner of SpyGlass Pharma, Inc. (SGP). Signal8 also holds filings tied to 3 other companies.
Signal8 holds 9 ownership filings by Walker Paul Edward (2 Form 3, 6 Form 4, 1 Form 5), filed between Sep 12, 2024 and Mar 12, 2026. Those filings report 37 transactions, from Sep 16, 2024 to Mar 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Walker Paul Edward's filings is in NEW YORK, NY.
Recent filings by Walker Paul Edward
- Mar 10, 2026: Open-market purchase of KRRO shares (Form 4, code P).
- Feb 9, 2026: Conversions of SGP shares (4 lines, Form 4, code C).
- Feb 9, 2026: Open-market purchase of SGP shares (Form 4, code P).
- Feb 9, 2026: Conversions of SGP shares (2 lines, Form 4, code C).
- Oct 2, 2025: Grant or award of NEUE derivative securities (Form 4, code A).
Other insiders filing for Korro Bio, Inc. (KRRO)
- Lynx1 Capital Management LP, 10% Owner
- FORMELA JEAN FRANCOIS, Director
- Dolan Oliver, Senior Vice President, Finance
- Aiyar Ram, President and CEO
- Vincent Loic A, Chief Scientific Officer
- Cerio Jeffrey, General Counsel